Hopwood P, Stephens RJ, Bleehen NM, Bolger JJ, Clark PI, Girling DJ, et al. Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br J Cancer. 1995;71(3):633–6. https://doi.org/10.1038/BJC.1995.124.

Lutz S, Spence C, Chow E, Janjan N, Connor S. Survey on use of palliative radiotherapy in hospice care. J Clin Oncol. 2004;22(17):3581–6. https://doi.org/10.1200/JCO.2004.11.151.

Article  PubMed  Google Scholar 

Lutz S, Balboni T, Jones J, Lo S, Petit J, Rich SE, et al. Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017;7(1):4–12. https://doi.org/10.1016/J.PRRO.2016.08.001.

Article  PubMed  Google Scholar 

Jumeau R, Vilotte F, Durham AD, Ozsahin EM. Current landscape of palliative radiotherapy for non-small-cell lung cancer. Transl Lung Cancer Res. 2019;8(Suppl 2):S192–201. https://doi.org/10.21037/TLCR.2019.08.10.

Fairchild A, Barnes E, Ghosh S, Ben-Josef E, Roos D, Hartsell W, et al. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice? Int J Radiat Oncol Biol Phys. 2009;75(5):1501–10. https://doi.org/10.1016/J.IJROBP.2008.12.084.

Article  PubMed  Google Scholar 

Chow E, Davis L, Panzarella T, Hayter C, Szumacher E, Loblaw A, et al. Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys. 2005;61(3):870–3. https://doi.org/10.1016/J.IJROBP.2004.07.697.

Article  PubMed  Google Scholar 

Gripp S, Moeller S, Bölke E, Schmitt G, Matuschek C, Asgari S, et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol. 2007;25(22):3313–20. https://doi.org/10.1200/JCO.2006.10.5411.

Article  PubMed  Google Scholar 

Fairchild A, Debenham B, Danielson B, Huang F, Ghosh S. Comparative multidisciplinary prediction of survival in patients with advanced cancer. Support Care Cancer. 2014;22(3):611–7. https://doi.org/10.1007/S00520-013-2013-2.

Article  CAS  PubMed  Google Scholar 

Koshy M, Malik R, Mahmood U, Husain Z, Weichselbaum RR, Sher DJ. Prevalence and predictors of inappropriate delivery of palliative thoracic radiotherapy for metastatic lung cancer. J Natl Cancer Inst. 2015;107(12):djv278. https://doi.org/10.1093/JNCI/DJV278.

Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13–22. https://doi.org/10.1093/BIOMET/73.1.13.

Article  Google Scholar 

Højsgaard S, Halekoh U, Yan J. The R package geepack for generalized estimating equations. J Stat Softw. 2005;15(2):1–11. https://doi.org/10.18637/jss.v015.i02.

Gillespie EF, Yang JC, Mathis NJ, Marine CB, White C, Zhang Z, et al. Prophylactic radiation therapy versus standard of care for patients with high-risk asymptomatic bone metastases: a multicenter, randomized phase II clinical trial. J Clin Oncol. 2024;42:38–46. https://doi.org/10.1200/JCO.23.00753.

Falk SJ, Girling DJ, White RJ, Hopwood P, Harvey A, Qian W, et al. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: Randomised controlled trial. British Medical Journal. 2002;325. https://doi.org/10.1136/bmj.325.7362.465.

Li H, Zhao Y, Ma T, Shao H, Wang T, Jin S, et al. Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era. Front Immunol. 2023;14. https://doi.org/10.3389/FIMMU.2023.1132482.

Arbour KC, Riely GJ. Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. JAMA. 2019;322:764–74. https://doi.org/10.1001/JAMA.2019.11058.

Article  CAS  PubMed  Google Scholar 

Nagappan PG, Chen H, Wang DY. Neuroregeneration and plasticity: a review of the physiological mechanisms for achieving functional recovery postinjury. Mil Med Res. 2020;7:30. https://doi.org/10.1186/S40779-020-00259-3.

Article  PubMed  PubMed Central  Google Scholar 

Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643–8. https://doi.org/10.1016/S0140-6736(05)66954-1.

Article  PubMed  Google Scholar 

Ryu S, Deshmukh S, Timmerman RD, Movsas B, Gerszten P, Yin FF, et al. Stereotactic radiosurgery vs conventional radiotherapy for localized vertebral metastases of the spine: phase 3 results of NRG Oncology/RTOG 0631 randomized clinical trial. JAMA Oncol. 2023;9(6):800–7. https://doi.org/10.1001/JAMAONCOL.2023.0356.

Article  PubMed  PubMed Central  Google Scholar 

Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer. 2000;8(3):175–9. https://doi.org/10.1007/S005200050281.

Article  CAS  PubMed  Google Scholar 

Anakura M, Nachankar A, Kobayashi D, Amornwichet N, Hirota Y, Shibata A, et al. Radiosensitivity differences between EGFR mutant and wild-type lung cancer cells are larger at lower doses. Int J Mol Sci. 2019;20(15):3635. https://doi.org/10.3390/IJMS20153635.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee HL, Chung TS, Ting LL, Tsai JT, Chen SW, Chiou JF, et al. EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases. Radiat Oncol. 2012;7:181. https://doi.org/10.1186/1748-717X-7-181.

Article  PubMed  PubMed Central  Google Scholar 

Truntzer P, Atlani D, Pop M, Clavier JB, Guihard S, Schumacher C, et al. Early evaluation predicts pain relief of irradiated bone metastases: a single-center prospective study. BMC Palliat Care. 2013;12:12. https://doi.org/10.1186/1472-684X-12-12.

Article  PubMed  PubMed Central  Google Scholar 

McDonald R, Ding K, Brundage M, Meyer RM, Nabid A, Chabot P, et al. Effect of radiotherapy on painful bone metastases: a secondary analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23. JAMA Oncol. 2017;3(7):953–9. https://doi.org/10.1001/JAMAONCOL.2016.6770.

Saito T, Toya R, Tomitaka E, Matsuyama T, Ninomura S, Oya N. Predictors of pain palliation after radiation therapy for painful tumors: a prospective observational study. Int J Radiat Oncol Biol Phys. 2018;101(5):1061–8. https://doi.org/10.1016/j.ijrobp.2018.04.072.

Article  PubMed  Google Scholar 

Li KK, Hadi S, Kirou-Mauro A, Chow E. When should we define the response rates in the treatment of bone metastases by palliative radiotherapy? Clin Oncol (R Coll Radiol). 2008;20(1):83–9. https://doi.org/10.1016/J.CLON.2007.09.009.

Article  CAS  PubMed  Google Scholar 

O’Brien MER, Borthwick A, Rigg A, Leary A, Assersohn L, Last K, et al. Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients. Br J Cancer. 2006;95(12):1632–6. https://doi.org/10.1038/SJ.BJC.6603498.

Article  PubMed  PubMed Central  Google Scholar 

Wallington M, Saxon EB, Bomb M, Smittenaar R, Wickenden M, McPhail S, et al. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study. Lancet Oncol. 2016;17(9):1203–16. https://doi.org/10.1016/S1470-2045(16)30383-7.

Article  PubMed  PubMed Central  Google Scholar 

Fraser I, Lefresne S, Regan J, Berthelet E, Chooback N, Ho C, et al. Palliative thoracic radiotherapy near the end of life in lung cancer: a population-based analysis. Lung Cancer. 2019;135:97–103. https://doi.org/10.1016/J.LUNGCAN.2019.02.024.

Article  PubMed  Google Scholar 

Oorschot BV, Assenbrunner B, Schuler M, Beckmann G, Flentje M. Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer. Strahlenther Onkol. 2014;190(3):270–5. https://doi.org/10.1007/S00066-013-0507-Y.

Article  PubMed  Google Scholar 

Wu SY, Singer L, Boreta L, Garcia MA, Fogh SE, Braunstein SE. Palliative radiotherapy near the end of life. BMC Palliat Care. 2019;18(1):29. https://doi.org/10.1186/S12904-019-0415-8.

Article  PubMed  PubMed Central  Google Scholar 

Spencer K, Morris E, Dugdale E, Newsham A, Sebag-Montefiore D, Turner R, et al. 30 day mortality in adult palliative radiotherapy – a retrospective population based study of 14,972 treatment episodes. Radiother Oncol. 2015;115(2):264–71. https://doi.org/10.1016/J.RADONC.2015.03.023.

Article  PubMed  PubMed Central  Google Scholar 

Walasek T, Sas-Korczyńska B, Dabrowski T, Reinfuss M, Jakubowicz J, Blecharz P, et al. Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status. Lung Cancer. 2015;87(2):130–5. https://doi.org/10.1016/J.LUNGCAN.2014.11.015.

Article  PubMed  Google Scholar 

Tiwana MS, Barnes M, Kiraly A, Olson RA. Utilization of palliative radiotherapy for bone metastases near end of life in a population-based cohort. BMC Palliat Care. 2016;15:2. https://doi.org/10.1186/S12904-015-0072-5/.

Article  PubMed  PubMed Central  Google Scholar 

Tseng YD, Gouwens NW, Lo SS, Halasz LM, Spady P, Mezheritsky I, et al. Use of radiation therapy within the last year of life among cancer patients. Int J Radiat Oncol Biol Phys. 2018;101(1):21–9. https://doi.org/10.1016/J.IJROBP.2018.01.056.

Article  PubMed